Mulmit

Aspire Biopharma Holdings, Inc.Aspire Biopharma Holdings, Inc.

ASBP Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-316,202-19,351,291-24,480,848-16.38

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-06-05Fell Donald G.10,500
2025-06-04Fell Donald G.9,500
2023-08-18PowerUp Sponsor LLC4,317,500
2023-05-18PowerUp Sponsor LLC7,187,500
2023-05-18PowerUp Sponsor LLC7,187,500

8-K events

FiledItems
2026-09-09Amendments to charter or bylaws · Other events · Financial statements and exhibits
2026-09-08Regulation FD disclosure · Financial statements and exhibits
2026-08-19Regulation FD disclosure · Financial statements and exhibits
2026-08-10Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-07-20Other events
2026-06-22Submission of matters to a vote
2026-06-12Other events
2026-06-12Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.